Aessoa by Oreon Life Science is a new line of 4 monophasic hyaluronic acid fillers used to improve skin miniaturization, correct superficial to deep wrinkles, increase volume, contour facial areas, and tighten pores. Aessoa is the first monophasic hyaluronic acid filler including lidocaine that combines smaller particle sizes with long-lasting effectiveness. It consists of a high concentration of hyaluronic acid (24mg/ml) and natural substances used to provide the skin with the necessary nutrients, volume, and skin moisture. Aessoa fillers deliver long-lasting results in up to 12-18 months depending on the treatment.
Aessoa is developed, manufactured, and launched in 2020 by OREON Life science. The Aessoa range offer four products with different properties to suit all needs:
Aessoa Deep Lidocaine - Intended for correcting deep wrinkles and folds.
Aessoa Global Lidocaine - Used to treat fine to moderate wrinkles and contour the lips.
Aessoa Shine Lidocaine - Used to tighten pores and moisturize the superficial dermis.
Aessoa Ultra Lidocaine - Ideal for midface treatments to lift and create ultimate structure.
MONOPHASIC VS. BIPHASIC DERMAL FILLERS:
Aessoa is the worlds’ leading brand within monophasic fillers with lidocaine providing unique benefits compared to Biphasic fillers. The monophasic structure makes the gel easier to form and spread smoothly while providing a more natural result with volumizing and wrinkle correction than biphasic fillers.